Parkinson Disease: Clinical Trials

172 trials for Parkinson Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

105 completed, 28 unknown, 17 terminated, 10 recruiting. 172 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4172Completed 105, Unknown 28, Terminated 17, Recruiting 10, Not yet recruiting 5, Withdrawn 4, Active not recruiting 1, Enrolling by invitation 1, Suspended 1

Follow Parkinson Disease: new trials by email Literature Review of Parkinson Disease trials Research Report on Parkinson Disease

Trials (filtered) newest first · largest first

All 172 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics
Levodopa (L-dopa) - Parkinson's Disease
Phase 4Not yet recruitingBeth Israel Deaconess Medical Center402027-07-012026-08-28
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease
Phase 4RecruitingVA Office of Research and Development1462026-11-092026-11-17
Metformin in Parkinson's Disease: Safety and Efficacy
Metformin 500mg - Parkinsons Disease (PD)
Phase 4Not yet recruitingJinnah Medical & Dental College702026-08-282026-09-09
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Lemborexant, placebo - Parkinson's Disease, Insomnia
Phase 4Not yet recruitingYangPan442026-08-192026-06-11
Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
Overactive bladder antimuscarinic deprescribing - Parkinson Disease (PD)
Phase 4Not yet recruitingCorporal Michael J. Crescenz VA Medical Center202026-06-012026-06-04
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
OraFID dosing device, Levodopa/Carbidopa minitablets delivered via OraFID dosing device - PARKINSON DISEASE (Disorder)
Phase 4RecruitingNavamedic AB582026-05-252026-09-24
EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial
Crisugabalin, Placebo - PARKINSON DISEASE (Disorder)
Phase 4Active not recruitingGuangdong Provincial People's Hospital1662026-03-132026-09-14
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
CREXONT ER - Parkinson Disease
Phase 4RecruitingThe Cleveland Clinic222025-07-242026-10-15
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
CREXONT ER - Parkinson Disease
Phase 4RecruitingImpax Laboratories, LLC2202025-02-122025-08-24
Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease
Vortioxetine (tablet) - Parkinson Disease, Idiopathic, Freezing of Gait
Phase 4Not yet recruitingMarianna Amboni402025-02-012025-02-06
Imaging Biomarkers of FOG Response to DBS
fMRI - Freezing of Gait Symptoms in Parkinson's Disease, Deep Brain Stimulation
Phase 4RecruitingMedical University of South Carolina542024-11-112026-08-10
Anti-Diabetic Medications to Fight PD and LBD
Sitagliptin, Dapagliflozin, Placebo - Lewy Body Dementia, Parkinson Disease
Phase 4CompletedMayo Clinic182024-05-072026-01-28
Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients
Terazosin - Parkinson Disease, Gait Analysis
Phase 4UnknownI.R.C.C.S. Fondazione Santa Lucia502023-12-012023-09-22
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
levodopa/carbidopa/entacapone - Parkinson Disease
Phase 4UnknownSecond Affiliated Hospital of Soochow University602023-11-152024-02-01
DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease
STIM ON plus, MED ON plus - Freezing of Gait, Parkinson Disease
Phase 4RecruitingIRCCS Istituto delle Scienze Neurologiche di Bologna202023-10-102024-03-18
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
Levodopa - Parkinson Disease, Treatment Adherence
Phase 4UnknownAnkara Ataturk Sanatorium Training and Research Hospital962023-10-012023-11-28
Personalized Real-Time DBS and PD Mechanisms
Neurostimulation, Carbidopa 25/Levodopa 100Mg Tab - Parkinson Disease
Phase 4RecruitingDavid Escobar252023-08-292026-08-20
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Pimavanserin - Neurodegenerative Diseases, Parkinson Disease
Phase 4RecruitingVanderbilt University Medical Center752023-01-232026-08-07
Istradefylline Effect Protocol on Parkinson's Disease Tremor
Istradefylline Pill - Parkinson Disease, Tremor
Phase 4CompletedGeorgetown University272023-01-202025-03-13
Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease
PD-RBD, iRBD - Parkinson Disease, Movement Disorders
Phase 4RecruitingBeijing Friendship Hospital1202022-09-012024-12-02

Showing 20 of 172. Sign in to see all of them.

Narrower conditions

Depression (8)  ·  Urinary Bladder, Overactive (7)  ·  Dyskinesias (6)  ·  Parkinsonian Disorders (5)  ·  Cognitive Dysfunction (4)  ·  Dementia (4)  ·  Parasomnias (4)  ·  Gait Disorders, Neurologic (3)  ·  Movement Disorders (3)  ·  Multiple System Atrophy (3)  ·  Neurodegenerative Diseases (3)  ·  Sleep Wake Disorders (3)  ·  Urinary Incontinence (3)  ·  Anosmia (2)

Broader conditions

Synucleinopathies (172)  ·  Basal Ganglia Diseases (170)  ·  Brain Diseases (170)  ·  Central Nervous System Diseases (170)  ·  Nervous System Diseases (170)  ·  Movement Disorders (169)  ·  Neurodegenerative Diseases (169)  ·  Parkinsonian Disorders (167)  ·  Pathological Conditions, Signs and Symptoms (42)  ·  Signs and Symptoms (42)  ·  Mental Disorders (28)  ·  Neurologic Manifestations (27)  ·  Behavior (13)  ·  Male Urogenital Diseases (11)  ·  Urogenital Diseases (11)

Interventions

rasagiline (16)  ·  Levodopa (15)  ·  carbidopa, levodopa drug combination (10)  ·  Pramipexole (9)  ·  Stalevo (8)  ·  Sugars (8)  ·  rotigotine (8)  ·  Apomorphine (5)  ·  Carbidopa (5)  ·  Dexmedetomidine (5)  ·  Droxidopa (5)  ·  Amantadine (4)  ·  Selegiline (4)  ·  entacapone (4)  ·  mirabegron (4)

Sponsors

Boehringer Ingelheim (7)  ·  Seoul National University Hospital (7)  ·  Baylor College of Medicine (4)  ·  Technische Universität Dresden (4)  ·  University of South Florida (4)  ·  Bial - Portela C S.A. (3)  ·  GlaxoSmithKline (3)  ·  IRCCS San Raffaele Roma (3)  ·  Novartis (3)  ·  Oregon Health and Science University (3)  ·  Orion Corporation, Orion Pharma (3)  ·  Second Affiliated Hospital of Soochow University (3)  ·  University of Pennsylvania (3)  ·  Amsterdam UMC, location VUmc (2)  ·  Beijing Friendship Hospital (2)

Countries

United States (72)  ·  Germany (18)  ·  France (17)  ·  South Korea (15)  ·  Italy (13)  ·  Spain (12)  ·  China (10)  ·  Austria (7)  ·  Sweden (7)  ·  United Kingdom (6)  ·  Slovakia (5)  ·  Canada (4)  ·  Finland (4)  ·  Netherlands (4)  ·  Russia (3)

Top investigators

Beom S Jeon, MD, PhD (3)  ·  Daniel Weintraub, MD (3)  ·  William G Ondo, MD (3)  ·  Alberto Espay, MD (2)  ·  David Devos, MD, PhD (2)  ·  Eungseok Oh (2)  ·  Jee-Young Lee, MD, PhD (2)  ·  Jinse Park (2)  ·  Jisun Kim (2)  ·  Theresa A Zesiewicz, MD (2)

Results publications

PMID 15372588, PMID 15975946, PMID 16024174, PMID 16805724, PMID 18052566, PMID 18442130, PMID 18583104, PMID 18673165, PMID 18784476, PMID 19855267, PMID 19917989, PMID 20142347, PMID 20332641, PMID 20452823, PMID 20535621, PMID 20679638, PMID 20841416, PMID 21464430, PMID 21553090, PMID 21733283, PMID 21772140, PMID 22549097, PMID 22658702, PMID 22841616, PMID 23077087, PMID 23185280, PMID 23196037, PMID 23406026, PMID 23408503, PMID 23697520, PMID 23726851, PMID 23847120, PMID 24004540, PMID 24078735, PMID 24299497, PMID 25037206, PMID 25079803, PMID 25399678, PMID 25805645, PMID 26095948, PMID 26347184, PMID 26795874, PMID 27267880, PMID 27322571, PMID 27506638, PMID 27942720, PMID 28078162, PMID 28265478, PMID 29452685, PMID 29705555

NIH funding

2008 (3), 2009 (1), 2014 (1), 2015 (1), 2017 (1), 2018 (1), 2025 (1), I01RD000466 (1), K23AG044441 (1), K23DK144718 (1), K23MH067894 (1), P30AG028747 (1), P50NS062684 (1), P50NS123103 (1), R01AG059417 (1)